What sector does Kailera Therapeutics Inc belong to?

Kailera Therapeutics Inc (KLRA) is in the Biotechnology sector / Biotechnology industry, listed on NASDAQ NMS - GLOBAL MARKET.

What is a 13F report?

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

Smart Money Tracker

KLRA

Kailera Therapeutics Inc

Held by 0 Wall Street gurus.

0Holders

0.00%Avg. Weight

--Total Value

0New Buys

Price Chart

KLRA

차트 불러오는 중

Fundamentals

Market Cap$2.50B

P/E Ratio--

EPS--

52W High--

52W Low--

SectorBiotechnology

ExchangeNASDAQ NMS - GLOBAL MARKET

Holders (0)

13F · by weight

No holdings recorded yet.

Insider Trades (6)

View all

Insider	Title	Type	Shares	Value	Date
Tregoning Kathleen	See Remarks	BUY	175,000	$4.1M	7/6/2026
Renaud Ronald C JR	CEO & President	SELL	38,094	$0.2M	6/9/2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	--	SELL	9,477,719	--	4/20/2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	--	SELL	2,034,133	--	4/20/2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	--	SELL	4,968,789	--	4/20/2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	--	SELL	708,814	--	4/20/2026